Adsorption, Distribution, Metabolism, Excretion (ADME), Efficacy, and Toxicology for BACE Inhibitors

BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Volumn , Issue , 2010, Pages 177-196

  Hussain, Ishrut ^a   Demont, Emmanuel ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adsorption, distribution, metabolism, excretion (ADME), efficacy and BACE inhibitor toxicology; BACE inhibitor toxicology; BACE inhibitors with optimized ADME properties

Indexed keywords

EID: 84873640016     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470594087.ch8     Document Type: Chapter

References (43)

1. Glenner, G.G. and Wong, C.W. 1984 . Alzheimer' s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein . Biochem Biophys Res Comm 120 : 885-890 .
2. Goedert, M., Wischik, C.M., Crowther, R.A., Walker, J.E., and Klug, A. 1988 . Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau . Proc Natl Acad Sci U S A 85 : 4051-4055 .
3. Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Murphy, K.E., Southan, C.D., Ryan, D.M., Smith, T.S., Simmons, D.L., Walsh, F.S., Dingwall, C., and Christie, G. 1999 . Identification of a novel aspartic protease (Asp2) as β-secretase . Mol Cell Neurosci 14 : 419-427 .
4. Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G., and Citron, M. 1999 . β-secretase cleavage of Alzheimer' s amyloid precursor protein by the transmembrane aspartic protease BACE . Science 286 : 735-741 .
5. Yan, R., Bienkowski, M.J., Shuck, M.E., Miao, H., Tory, M.C., Pauley, A.M., Brashier, J.R., Stratman, N.C., Mathews, W.R., Buhl, A.E., Carter, D.B., Tomasselli, A.G., Parodi, L.A., Heinrikson, R.L., and Gurney, M.E. 1999 . Membrane-anchored aspartyl protease with Alzheimer' s disease β-secretase activity . Nature 402 : 533-537 .
6. Sinha, S., Anderson, J.P., Barbour, R., Basi, G.S., Caccavello, R., Davis, D., Doan, M., Dovey, H.F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S.M., Wang, S., Walker, D., Zhao, J., McConlogue, L., and John, V. 1999 . Purification and cloning of amyloid precursor protein β-secretase from human brain . Nature 402 : 537-540 .
7. Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A.K., Zhang, X.C., and Tang, J. 2000 . Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor . Science 290 : 150-153 .
8. Eder, J., Hommel, U., Cumin, F., Martoglio, B., and Gerhartz, B. 2007 . Aspartic proteases in drug discovery . Cur Pharm Des 12 : 271-285 .
9. Muller, D.N. and Luft, F.C. 2006 . Direct renin inhibition with Aliskiren in hypertension and target organ damage . Clin J Am Soc Nephrol 1 : 221-228 .
10. Abbenante, G. and Fairlie, D.P. 2005 . Protease inhibitors in the clinic . Med Chem 1 : 71-104 .
11. Savolainen, J., Edwards, J.E., Morgan, M.E., McNamara, P.J., and Anderson, B.D. 2002 . Effects of a P-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administrated in combination in rats . Drug Metab Dispos 30 : 479-482 .
12. Cooper, C.L., Van Heeswijk, R.P.G., Gallicano, K., and Cameron, D.W. 2003 . A review of low-dose ritonavir in protease inhibitor combination therapy . HIV/AIDS 36 : 1585-1592 .
13. Ghosh, A.K., Bilcer, G., Harwood, C., Kawahama, R., Shin, D., Hussain, K.A., Hong, L., Loy, J.A., Nguyen, C., Koelsch, G., Ermolieff, J., and Tang, J . 2001 . Structure-based design: potent inhibitors of human brain memapsin 2 ( β-secretase) . J Med Chem 44 : 2865-2868 .
14. Tung, J.S., Davis, D.L., Anderson, J.P., Walker, D.E., Mamo, S., Jewett, N., Hom, R.K., Sinha, S., Thorsett, E.D., and John, V. 2002 . Design of substrate-based inhibitors of human β-secretase . J Med Chem 45 : 259-262 .
15. Hom, R.K., Fang, L.Y., Mamo, S., Tung, J.S., Guinn, A.C., Walker, D.E., Davis, D.L., Gailunas, A.F., Thorsett, E.D., Sinha, S., Knops, J.E., Jewett, N.E., Anderson, J.P., and John, V. 2003 . Design and synthesis of statine-based cell-permeable peptidomimetic inhibitors of human β-secretase . J Med Chem 46 : 1799-1802 .
16. Hom, R.K., Gailunas, A.F., Mamo, S., Fang, L.Y., Tung, J.S., Walker, D.E., Davis, D., Thorsett, E.D., Jewett, N.E., Moon, J.B., and John, V. 2004 . Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human β-secretase . J Med Chem 47 : 158-164 .
17. Coburn, C.A., Stachel, S.J., Li, Y.-M., Rush, D.M., Steele, T.G., Chen-Dodson, E., Holloway, M.K., Xu, M., Huang, Q., Lai, M.-T., Shi, X.-P., Sardana, V., Chen, Z., Munshi, S., Kuo, L., Makara, G.M., Annis, D.A., Tadikonda, P.K., Nash, H.M., Vacca, J.P., and Wang, T. 2004 . Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a non-traditional binding mode for aspartyl proteases . J Med Chem 47 : 6117-6119 .
18. Stachel, S.J., Coburn, C.A., Steele, T.G., Jones, K.G., Loutzenhiser, E.F., Gregro, A.R., Rajapakse, H.A., Lai, M.-T., Crouthamel, M.-C., Xu, M., Tugusheva, K., Lineberger, J.E., Pietrak, B.L., Espeseth, A.S., Shi, X.-P., Chen-Dodson, E., Holloway, M.K., Munshi, S., Simon, A.J., Kuo, L., and Vacca, J.P. 2004 . Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1) . J Med Chem 47 : 6447-6450 .
19. Stachel, S.J., Coburn, C.A., Steele, T.G., Crouthamel, M.-C., Pietrak, B.L., Lai, M.-T., Holloway, M.K., Munshi, S.K., Graham, S.L., and Vacca, J.P. 2006 . Conformationally biased P3 amide replacements of β-secretase inhibitors . Bioorg Med Chem Lett 16 : 641-644 .
20. Coburn, C.A., Stachel, S.J., Jones, K.G., Steele, T.G., Rush, D.M., DiMuzio, J., Pietrak, B.L., Lai, M.-T., Huang, Q., Lineberger, J., Jin, L., Munshi, S., Holloway, M.K., Espeseth, A., Simon, A., Hazuda, D., Graham, S.L., and Vacca, J.P. 2006 . BACE-1 inhibition by a series of ψ[CH2NH] reduced amide isosteres . Bioorg Med Chem Lett 16 : 3635-3638 .
21. Stachel, S.J., Coburn, C.A., Sankaranarayanan, S., Price, E.A., Pietrak, B.L., Huang, Q., Lineberger, J., Espeseth, A.S., Jin, L., Ellis, J., Holloway, M.K., Munshi, S., Allison, T., Hazuda, D., Simon, A.J., Graham, S.L., and Vacca, J.P. 2006 . Macrocyclic inhibitors of β-secretase: functional activity in an animal model . J Med Chem 49 : 6147-6150 .
22. Rajapakse, H.A., Nantermet, P.G., Selnick, H.G., Munshi, S., McGaughey, G.B., Lindsley, S.R., Young, M.B., Lai, M.-T., Espeseth, A.S., Shi, X.-P., Colussi, D., Pietrak, B., Crouthamel, M.-C., Tugusheva, K., Huang, Q., Xu, M., Simon, A.J., Kuo, L., Hazuda, D.J., Graham, S., and Vacca, J.P. 2006 . Discovery of oxadiazoyl tertiary carbinamine inhibitors of β-secreatse (BACE-1) . J Med Chem 49 : 7270-7273 .
23. McGauchey, G.B., Colussi, D., Graham, S.L., Lai, M.-T., Munshi, S.K., Nantermet, P.G., Pietrak, B., Rajapakse, H.A., Selnick, H.G., Stauffer, S.R., and Holloway, M.K. 2007 . β-secretase (BACE-1) inhibitors: accounting for 10s loop flexibility using rigid active sites . Bioorg Med Chem Lett 17 : 1117-1121 .
24. Stauffer, S.R., Stanton, M.G., Gregro, A.R., Steinbeiser, M.A., Shaffer, J.R., Nantermet, P.G., Barrow, J.C., Rittle, K.E., Colussi, D., Espeseth, A.S., Lai, M.-T., Pietrak, B.L., Holloway, M.K., McGaughey, G.B., Munshi, S.K., Hochman, J.H., Simon, A.J., Selnick, H.G., Graham, S.L., and Vacca, J.P. 2007 . Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in an N-terminal 10s-loop down comformation . Bioorg Med Chem Lett 17 : 1788-1792 .
25. Sankaranarayanan, S., Holahan, M.A., Colussi, D., Crouthamel, M.C., Devanarayan, V., Ellis, J., Espeseth, A., Gates, A.T., Graham, S.L., Gregro, A.R., Hazuda, D., Hochman, J.H., Holloway, K., Jin, L., Kahana, J., Lai, M.T., Lineberger, J., McGaughey, G., Moore, K.P., Nantermet, P., Pietrak, B., Price, E.A., Rajapakse, H., Stauffer, S., Steinbeiser, M.A., Seabrook, G., Selnick, H.G., Shi, X.P., Stanton, M.G., Swestock, J., Tugusheva, K., Tyler, K.X., Vacca, J.P., Wong, J., Wu, G., Xu, M., Cook, J.J., and Simon, A.J. 2009 . First demonstration of CSF and plasma A β lowering with oral administration of a BACE1 inhibitor in nonhuman primates . J Pharmacol Exp Ther 328 : 131-140 .
26. Stanton, M.G., Stauffer, S.R., Gregro, A.R., Steinbeiser, M., Nantermet, P., Sankaranarayanan, S., Price, E.A., Wu, G., Crouthamel, M.-C., Ellis, J., Lai, M.-T., Espeseth, A.S., Shi, X.-P., Jin, L., Colussi, D., Pietrak, B., Huang, Q., Xu, M., Simon, A.J., Graham, S.L., Vacca, J.P., and Selnick, H. 2007 . Discovery of isonicotinamide derived β-secretase inhibitors: in vivo reduction of γ-amyloid . J Med Chem 50 : 3431-3433 .
27. Clarke, B., Demont, E., Dingwall, C., Dunsdon, R., Faller, A., Hawkins, J., Hussain, I., MacPherson, D., Maile, G., Matico, R., Milner, P., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Riddell, D., Rowland, P., Soleil, V., Smith, K.J., Stanway, S., Stemp, G., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., Ward, J., and Wayne, G. 2008 . BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs) . Bioorg Med Chem Lett 18 : 1011-1016 .
28. Clarke, B., Demont, E., Dingwall, C., Dunsdon, R., Faller, A., Hawkins, J., Hussain, I., MacPherson, D., Maile, G., Matico, R., Milner, P., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Riddell, D., Rowland, P., Soleil, V., Smith, K.J., Stanway, S., Stemp, G., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., Ward, J., and Wayne, G. 2008 . BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character . Bioorg Med Chem Lett 18 : 1017-1021 .
29. Beswick, P., Charrier, N., Clarke, B., Demont, E., Dingwall, C., Dunsdon, R., Faller, A., Gleave, R., Hawkins, J., Hussain, I., Johnson, C.N., MacPherson, D., Maile, G., Matico, R., Milner, P., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Riddell, D., Rowland, P., Soleil, V., Skidmore, J., Smith, K.J., Stanway, S., Stemp, G., Stuart, A., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., Ward, J., and Wayne, G. 2008 . BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells . Bioorg Med Chem Lett 18 : 1022-1026 .
30. Charrier, N., Clarke, B., Cutler, L., Demont, E., Dingwall, C., Dunsdon, R., East, P., Hawkins, J., Howes, C., Hussain, I., Jeffrey, P., Maile, G., Matico, R., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Rowland, P., Soleil, V., Smith, K.J., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., and Wayne, G. 2008 . Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailability . J Med Chem 51 : 3313-3317 .
31. Iserloh, U., Pan, J., Stamford, A.W., Kennedy, M.E., Zhang, Q., Zhang, L., Parker, E.M., McHugh, N.A., Favreau, L., Strickland, C., and Voigt, J. 2008 . Disocvery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor . B ioorg Med Chem Lett 18 : 418-422 .
32. McGowan, E., Eriksen, J., and Hutton, M. 2006 . A decade of modeling Alzheimer' s disease in transgenic mice . Trends Genet 22 : 281-289 .
33. Asai, M., Hattori, C., Iwata, N., Saido, T.C., Sasagawa, N., Szabó, B., Hashimoto, Y., Maruyama, K., Tanuma, S., Kiso, Y., and Ishiura, S. 2006 . The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice . J Neurochem 96 : 533-540 .
34. Nishitomi, K., Sakaguchi, G., Horikoshi, Y., Gray, A.J., Maeda, M., Hirata-Fukae, C., Becker, A.G., Hosono, M., Sakaguchi, I., Minami, S.S., Nakajima, Y., Li, H.F., Takeyama, C., Kihara, T., Ota, A., Wong, P.C., Aisen, P.S., Kato, A., Kinoshita, N., and Matsuoka, Y. 2006 . BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice . J Neurochem 99 : 1555-1563 .
35. Chang, W.P., Koelsch, G., Wong, S., Downs, D., Da, H., Weerasena, V., Gordon, B., Devasamudram, T., Bilcer, G., Ghosh, A.K., and Tang, J. 2004 . In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors . J Neurochem 89 : 1409-1416 .
36. Sankaranarayanan, S., Price, E.A., Wu, G., Crouthamel, M.C., Shi, X.P., Tugusheva, K., Tyler, K.X., Kahana, J., Ellis, J., Jin, L., Steele, T., Stachel, S., Coburn, C., and Simon, A.J. 2008 . In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1 . J Pharmacol Exp Ther 324 : 957-969 .
37. Baxter, E.W., Conway, K.A., Kennis, L., Bischoff, F., Mercken, M.H., Winter, H.L., Reynolds, C.H., Tounge, B.A., Luo, C., Scott, M.K., Huang, Y., Braeken, M., Pieters, S.M., Berthelot, D.J., Masure, S., Bruinzeel, W.D., Jordan, A.D., Parker, M.H., Boyd, R.E., Qu, J., Alexander, R.S., Brenneman, D.E., and Reitz, A.B. 2007 . 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): use of structure based design to convert a micromolar hit into a nanomolar lead . J Med Chem 50 : 4261-4264 .
38. Cumming, J.N., Le, T.X., Babu, S., Carroll, C., Chen, X., Favreau, L., Gaspari, P., Guo, T., Hobbs, D.W., Huang, Y., Iserloh, U., Kennedy, M.E., Kuvelkar, R., Li, G., Lowrie, J., McHugh, N.A., Ozgur, L., Pan, J., Parker, E.M., Saionz, K., Stamford, A.W., Strickland, C., Tadesse, D., Voigt, J., Wang, L., Wu, Y., Zhang, L., and Zhang, Q. 2008 . Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors . Bioorg Med Chem Lett 18 : 3236-3241 .
39. Hussain, I., Hawkins, J., Harrison, D., Hille, C., Wayne, G., Cutler, L., Buck, T., Walter, D., Demont, E., Howes, C., Naylor, A., Jeffrey, P., Gonzalez, M.I., Dingwall, C., Michel, A., Redshaw, S., and Davis, J.B. 2007 . Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo . J Neurochem 100 : 802-809 .
40. Meredith, J.E. Jr ., Thompson, L.A., Toyn, J.H., Marcin, L., Barten, D.M., Marcinkeviciene, J., Kopcho, L., Kim, Y., Lin, A., Guss, V., Burton, C., Iben, L., Polson, C., Cantone, J., Ford, M., Drexler, D., Fiedler, T., Lentz, K.A., Grace, J.E. Jr ., Kolb, J., Corsa, J., Pierdomenico, M., Jones, K., Olson, R.E., Macor, J.E., and Albright, C.F. 2008 . P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice . J Pharmacol Exp Ther 326 : 502-513 .
41. Nantermet, P.G., Rajapakse, H.A., Stanton, M.G., Stauffer, S.R., Barrow, J.C., Gregro, A.R., Moore, K.P., Steinbeiser, M.A., Swestock, J., Selnick, H.G., Graham, S.L., McGaughey, G.B., Colussi, D., Lai, M.T., Sankaranarayanan, S., Simon, A.J., Munshi, S., Cook, J.J., Holahan, M.A., Michener, M.S., and Vacca, J.P. 2008 . Evolution of tertiary carbinamine BACE-1 inhibitors: Abeta reduction in rhesus CSF upon oral dosing . ChemMedChem 4 : 37-40 .
42. Strobel, G. 2008 . Keystone Drug News: CoMentis BACE Inhibitor Debuts. Alzheimer Research Forum. Available at http://www.alzforum.org/new/detail.asp?id=1790 (accessed April 5, 2008).
43. Malamas, M., Erdei, J., Gunawan, I., Robichaud, A., Turner, J., Hu, Y., Wagner, E., Aschmies, S., Comery, T., Fan, K., Chopra, R., Magold, R., Pangalos, M., Reinhart, P., Riddell, D., Jacobsen, S., Abou-Gharbia, M., and Bard, J. 2008 . Small molecule BACE-1 inhibitors are potent, selective and orally active . Alzheimer' s and Dementia 4 : T515 .